Cargando…

Development of a long non-coding RNA signature for prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma

Standard treatment for locally advanced rectal adenocarcinoma (LARC) includes a combination of chemotherapy with pyrimidine analogues, such as capecitabine, and radiation therapy, followed by surgery. Currently no clinically useful genomic predictors of benefit from neoadjuvant chemoradiotherapy (nC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferrando, Lorenzo, Cirmena, Gabriella, Garuti, Anna, Scabini, Stefano, Grillo, Federica, Mastracci, Luca, Isnaldi, Edoardo, Marrone, Ciro, Gonella, Roberta, Murialdo, Roberto, Fiocca, Roberto, Romairone, Emanuele, Ballestrero, Alberto, Zoppoli, Gabriele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001901/ https://www.ncbi.nlm.nih.gov/pubmed/32023246 http://dx.doi.org/10.1371/journal.pone.0226595

Ejemplares similares

Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer
por: Isnaldi, Edoardo, et al.
Publicado: (2019)

The Multidisciplinary Approach of Rectal Cancer: The Experience of “COMRE Group” Model
por: Scabini, Stefano, et al.
Publicado: (2022)

The effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancer
por: Scabini, Stefano, et al.
Publicado: (2013)

Circulating Tumor DNA Using Tagged Targeted Deep Sequencing to Assess Minimal Residual Disease in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
por: Cirmena, Gabriella, et al.
Publicado: (2020)

Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases
por: Zoppoli, Gabriele, et al.
Publicado: (2017)

Plasma Cell-Free DNA Integrity Assessed by Automated Electrophoresis Predicts the Achievement of Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer
por: Cirmena, Gabriella, et al.
Publicado: (2022)

Colon and rectal surgery for cancer without mechanical bowel preparation: One-center randomized prospective trial
por: Scabini, Stefano, et al.
Publicado: (2010)

Retraction: colon and rectal surgery for cancer without mechanical bowel preparation: one-center randomized prospective trial
por: Scabini, Stefano, et al.
Publicado: (2012)

Predictive values of two frailty screening tools in older patients with solid cancer: a comparison of SAOP2 and G8
por: Russo, Chiara, et al.
Publicado: (2018)

HLA-G as a prognostic marker in stage II/III colorectal cancer: not quite there yet
por: Gambella, Alessandro, et al.
Publicado: (2022)

Multi-Gene Testing Overview with a Clinical Perspective in Metastatic Triple-Negative Breast Cancer
por: Dameri, Martina, et al.
Publicado: (2021)

Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer
por: Brown, David N., et al.
Publicado: (2016)

Assessment of Circulating Nucleic Acids in Cancer: From Current Status to Future Perspectives and Potential Clinical Applications
por: Cirmena, Gabriella, et al.
Publicado: (2021)

Incidence and immunomic features of apyretic COVID-19 in patients affected by solid tumors: a prospective cohort study
por: Ravera, Francesco, et al.
Publicado: (2022)

Targeting the Epidermal Growth Factor Receptor Can Counteract the Inhibition of Natural Killer Cell Function Exerted by Colorectal Tumor-Associated Fibroblasts
por: Costa, Delfina, et al.
Publicado: (2018)

Restaging rectal cancer following neoadjuvant chemoradiotherapy
por: Cuicchi, Dajana, et al.
Publicado: (2023)

Urachal tumour: case report of a poorly understood carcinoma
por: Scabini, Stefano, et al.
Publicado: (2009)

Retraction Note: Urachal tumour: case report of a poorly understood carcinoma
por: Scabini, Stefano, et al.
Publicado: (2021)

Lung fibrosis: an undervalued finding in COVID-19 pathological series
por: Grillo, Federica, et al.
Publicado: (2021)

PET/CT with Fluorodeoxyglucose During Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
por: Travaini, Laura L, et al.
Publicado: (2016)

The experience of the COMRE group (REctal COMmittee): can magnetic resonance imaging and endosonography really help the clinical pathway after NCRT in rectal cancer?
por: Scabini, Stefano, et al.
Publicado: (2023)

A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
por: Li, Yi, et al.
Publicado: (2016)

Recent advances in neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Kawai, Kazushige, et al.
Publicado: (2018)

Neoadjuvant FOLFIRINOX followed by Chemoradiotherapy for Middle and Lower Rectal Cancer
por: Sakr, Amr, et al.
Publicado: (2020)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
por: Lin, Huaqin, et al.
Publicado: (2021)

Development of a hoRizontal data intEgration classifier for NOn-invasive early diAgnosis of breasT cancEr: the RENOVATE study protocol
por: Ravera, Francesco, et al.
Publicado: (2021)

Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
por: Molinari, Chiara, et al.
Publicado: (2011)

Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
por: Tokuhara, Katsuji, et al.
Publicado: (2016)

Delaying surgery after neoadjuvant chemoradiotherapy improves prognosis of rectal cancer
por: Mihmanlı, Mehmet, et al.
Publicado: (2016)

Recent advances of neoadjuvant chemoradiotherapy in rectal cancer: Future treatment perspectives
por: Yamashita, Kimihiro, et al.
Publicado: (2018)

Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients
por: Mei, Shi-Wen, et al.
Publicado: (2020)

Automated Prediction of the Response to Neoadjuvant Chemoradiotherapy in Patients Affected by Rectal Cancer
por: Filitto, Giuseppe, et al.
Publicado: (2022)

Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
por: Hsu, Yu-Jen, et al.
Publicado: (2022)

Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy
por: Wang, Hanyang, et al.
Publicado: (2022)

Correlation between tumor regression grade and rectal volume in neoadjuvant concurrent chemoradiotherapy for rectal cancer
por: Lee, Hong Seok, et al.
Publicado: (2016)

Obesity may not be related to pathologic response in locally advanced rectal cancer following neoadjuvant chemoradiotherapy
por: Bao, Quoc Riccardo, et al.
Publicado: (2022)

MRI texture analysis in predicting treatment response to neoadjuvant chemoradiotherapy in rectal cancer
por: Meng, Yankai, et al.
Publicado: (2017)

Organ Preservation Strategies After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
por: Yoo, Ri Na, et al.
Publicado: (2019)

Genomic and Transcriptomic Characterisation of Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
por: Toomey, Sinead, et al.
Publicado: (2020)

Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer
por: Chen, Jia-Nan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9e2fu8giqeacpq7a77kulgcffh